Anticoagulant Therapy in Initially Low‐Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors

BACKGROUND: The CHA(2)DS(2)‐VASc score has been validated for stroke risk prediction in patients with atrial fibrillation (AF). Antithrombotic therapy is not recommended for low‐risk patients with AF (CHA(2)DS(2)‐VASc 0 [male] or 1 [female]). We studied a cohort of initially low‐risk patients with A...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Sun Young, Kim, Moo Hyun, Lee, Kwang Min, Cho, Young‐Rak, Park, Jong Sung, Kim, Seong Woo, Kim, Jin Kyung, Chung, Matthew, Yun, Sung‐Cheol, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660835/
https://www.ncbi.nlm.nih.gov/pubmed/32779499
http://dx.doi.org/10.1161/JAHA.120.016271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660835/
https://www.ncbi.nlm.nih.gov/pubmed/32779499
http://dx.doi.org/10.1161/JAHA.120.016271

Ejemplares similares